Arxis Completes the Acquisition of Omnetics Connector Corporation

Arxis closes $770M Omnetics deal, but value hinges on long-term earnings projections.

What the company is saying

Arxis, Inc. communicates the completion of its acquisition of Omnetics Connector Corporation, emphasizing the transaction's $770 million enterprise value and the issuance of 13,351,964 Class A shares, which now represent 3.1% of total common stock. The announcement frames Omnetics as a 'leading designer and manufacturer' in high-reliability connectors for defense, aerospace, and medical applications, but provides no supporting data for this claim. The company highlights the combined purchase price multiple of 12x FY27 estimated adjusted EBITDA, linking the deal to long-term earnings growth. Arxis states that Omnetics will be integrated into its Electronic Components Segment, though no operational details are disclosed. The narrative leans on Arcline Investment Management's $30 billion in assets under management and its stated institutional capabilities, presenting Arcline as a strategic partner. The tone is optimistic and forward-looking, with heavy emphasis on future growth and strategic positioning. Several claims about market leadership and institutional advantages are asserted without quantitative backing.

What the data suggests

The only concrete figures disclosed are the $770 million enterprise value for the Omnetics acquisition, the issuance of 13,351,964 Class A shares (3.1% of total common stock), and a purchase price multiple of 12x FY27 estimated adjusted EBITDA when combined with the MagCanica acquisition. No historical or pro forma financials, such as revenue, EBITDA, or cash flow, are provided for either Arxis or Omnetics. The use of a forward-looking FY27 EBITDA figure as the basis for the purchase price multiple signals that the deal's valuation relies on projections several years out, rather than current or trailing earnings. There is no disclosure of the actual or expected financial impact on Arxis' income statement, balance sheet, or cash flows. The lack of operational or segment data prevents assessment of integration risks or synergies. Assertions about Omnetics' market position and Arcline's capabilities are not substantiated with data. Overall, the data is limited to headline deal terms and does not allow for independent analysis of value creation.

Analysis

The announcement confirms the completion of the Omnetics acquisition, which is a realised milestone and supports a positive tone. However, the only financial metrics disclosed are the transaction value ($770 million), shares issued, and a forward-looking purchase price multiple based on FY27 estimated adjusted EBITDA. There is no disclosure of historical or pro forma profitability metrics (net income, EBITDA, operating profit, or cash flow), which limits the ability to assess the true financial impact or sustainability of the acquisition. Several claims, such as Omnetics' market leadership and Arcline's strategic capabilities, are promotional and unsupported by data. The use of a 12x FY27 estimated EBITDA multiple highlights that the valuation is based on long-term, uncertain projections rather than current earnings. The capital outlay is significant, but the benefits are not immediate and are tied to future estimates, increasing execution risk. Overall, the narrative is more optimistic than the measurable evidence justifies.

Risk flags

• ●The transaction's $770 million enterprise value and 12x FY27 estimated adjusted EBITDA multiple mean that Arxis is paying a premium based on long-term earnings projections, not current performance. If Omnetics underdelivers on these projections, the acquisition could be value-destructive.
• ●No historical or pro forma financials for Omnetics or the combined entity are disclosed, which prevents investors from assessing the baseline profitability, cash flow, or leverage impact. This lack of transparency increases the risk of negative surprises post-integration.
• ●Several claims about Omnetics' market leadership and Arcline's institutional capabilities are made without supporting data, raising the risk that the strategic rationale is overstated or unsubstantiated.
• ●The lockup provisions on the 13,351,964 newly issued shares (3.1% of total common stock) could create future overhang risk once restrictions expire, potentially impacting share price if former Omnetics shareholders choose to sell.
• ●Integration risks are not addressed; there is no information on how Omnetics will be operationally merged into Arxis' Electronic Components Segment, leaving uncertainty around execution and synergy realization.

Bottom line

Arxis has closed the $770 million acquisition of Omnetics, issuing 13.4 million new shares and betting on a 12x multiple of projected FY27 earnings. The announcement provides no historical or pro forma financials, so investors cannot gauge whether the deal is accretive or dilutive in the near term. Most claims about strategic fit, market leadership, and institutional support are qualitative and lack quantitative evidence. The value of this acquisition will only become clear if Omnetics delivers on long-term earnings targets, but the absence of current financial data and integration details heightens execution and valuation risk. Investors should treat the narrative with caution until Arxis discloses actual financial performance and integration progress. The most important takeaway is that this is a high-premium, long-horizon bet with limited short-term visibility.

Announcement summary

(NASDAQ: ARXS) Arxis, Inc. announced that it has completed its previously announced acquisition of Omnetics Connector Corporation. The transaction was based on an agreed enterprise value of approximately $770 million, subject to customary closing adjustments. At closing, Arxis issued 13,351,964 shares of its Class A common stock to the former Omnetics shareholders, representing approximately 3.1% of total common stock as of the closing date, which are subject to lockup provisions. The combined purchase price multiple with the MagCanica acquisition is approximately 12x FY27 estimated adjusted EBITDA. Omnetics will operate within Arxis' Electronic Components Segment.

Disagree with this article?